lobbying_activities: 1545772

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1545772	b972730c-965d-43d8-a292-1a5313a3e414	Q2	CSL BEHRING LLC	308935	CSL BEHRING LLC	2014	second_quarter	HCR	Preserving Access to Orphan Drugs Act (HR 2315/S.1128) Orphan Drug Tax Credit - highlighting its importance in orphan product development for treatment of rare diseases	HOUSE OF REPRESENTATIVES,SENATE		170000	0	0	2014-07-02T10:20:19.063000-04:00